Why Menopause Care Is the New Fertility: A Strategic Shift Investors Are Missing
Like IVF before it, midlife health is becoming reimbursed, institutionalized, and investable. Are you early or late to the next women’s health wave?
Midlife women’s health is no longer a wellness trend. It’s becoming infrastructure. This article breaks down how quiet deals, new care models, and employer demand are building the next emerging area of institutional interest.
Creating work like this is a choice. It takes time and effort to resist the pull toward noise and stay anchored in depth. If this newsletter has offered you something valuable, I invite you to consider supporting it, either with a one-time gift or a regular contribution. Your support helps me stay true to the kind of work that asks better questions, listens longer, and builds something lasting. I’m deeply grateful you’re here.
New here? Tap the subscribe button to follow along each week inside the app.
The Quiet Power Shift in Women’s Health: Why Midlife Care Is Becoming Institutionalized
In the early 2000s, fertility care wasn’t something people talked about. It lived in the background; unspoken, unfunded, often unseen. There were few clinics. No standard protocols. And if you were lucky enough to have access, it was quietly paid for out of pocket, not supported by any formal system.
And yet, over the span of a decade, it shifted.
Quietly at first, and then, all at once.
Companies like Progyny, Kindbody, and Carrot reframed fertility not as a personal issue, but as a workforce imperative and investment opportunity. (Progyny, n.d.; Carrot Fertility, n.d.) Employers came on board. Analysts built revenue models. Infrastructure followed. And today, 47% of large U.S. employers offer fertility benefits. (Mercer, 2024)
Fertility became infrastructure as capital support and system maturity aligned.
Now, midlife care; menopause, metabolic shifts, and hormone optimization is moving in the same direction. Except this time, we are watching the shift in real time.
Why Midlife Was Ignored Until Now
Midlife women’s health has been long overlooked not because it lacks demand, but because it didn’t fit neatly into the system.
It’s chronic. Hormonal. Nonlinear.
There was no CPT code for brain fog, no easy ROI model for sleep disruption or long-term cardiovascular risk. And so the market filled with wellness products and symptom checkers. High-churn, low-trust. Light on outcomes. Light on scale.
Venture capital, predictably, stayed away.
But as of 2024, the opportunity is no longer speculative. The global menopause market is projected to exceed $24 billion by 2030 (Pharmavite, 2024). And the business models are evolving beyond DTC supplements. We are seeing full-stack clinical platforms, payor-backed care, and vertically integrated service delivery.
The scaffolding is going up.
What LifeMD’s Quiet Deal Reveals
Earlier this month, LifeMD quietly acquired the clinical assets of Optimal Human Health, a menopause-focused care provider. No headline splash. No rebrand. Just protocols, licensed providers, and revenue-generating services brought in-house (GlobeNewswire, 2025).
Most readers barely noticed.
But for those tracking the institutionalization of women’s health, this was a clear signal. LifeMD didn’t buy a brand. It bought operating leverage.
This wasn’t a venture-style platform play. It was a margin strategy. A move that bypasses CAC, de-risks clinical rollout, and accelerates integration. These kinds of asset-based deals are common in more mature care sectors. Seeing them emerge in menopause signals that we are past the experimental phase.
As we noted in this week’s Signal Not Noise, this isn’t just a women’s health story. It’s a capital stack evolution story.
Signal Not Noise: What Mattered in Women’s Health Investing (Apr 27–May 3)
This week’s signals tell a different kind of story: the capital stack for women’s health is quietly evolving through asset deals, institutional alliances, and science-driven care platforms.
This newsletter is 100% free. But it takes hours each week to research, write, and produce at this level. If you’d like to support this work, even with a small contribution, I’d be so grateful.
Quiet Operators Are Building the Future
LifeMD’s move only makes sense because a foundation has already been laid by companies like:
Midi Health, now reimbursed by major payors and operating in all 50 states (Midi Health, 2024).
Bonafide Health, which has invested deeply in clinical trials to validate its non-prescription hormone support products (Hello Bonafide, n.d.).
Peppy Health, provides employer-sponsored digital health benefits across fertility, pregnancy, and menopause. (Peppy Health, n.d.).
These are not media brands or celebrity-backed DTC supplements. These are infrastructure plays. And they are structuring care in a way that makes scale credible, not aspirational.
But capital still flows disproportionately elsewhere.
❤️ Enjoying this?
If this post sparked something for you, click the ❤️ at the bottom. It helps more than you know and tells me you're reading.
Let’s Talk About the Blind Spot
You told us in last week’s poll that “The Next VC Blind Spot” was the story you wanted us to cover.
This is it.
In our upcoming podcast, I sit down with Sergei Polevikov, editor of AI Health Uncut, to unpack where investor attention is misaligned and what gets missed when capital chases noise over outcomes.
One thing we agreed on:
“There are companies quietly generating revenue and outcomes yet capital keeps rewarding the ones making the most noise. That’s not a pipeline problem. It’s a pattern-recognition problem.”
Midlife care isn’t niche. It’s the next underwritten, employer-backed, infrastructure-level shift in women’s health. But it’s being ignored for all the old reasons: unfamiliarity, lack of precedent, investor blinders.
So we are here to name it.
What Gets Built And Who It’s For
Most of healthcare was built around male physiology. Acute care. Linear timelines. Quantifiable endpoints.
Midlife care doesn’t fit that mould. But women’s health doesn’t need to fit the system to matter. It just needs a new one.
Fertility proved that. It showed us that with enough infrastructure, narrative, and capital coordination, care models once seen as “personal” could become investable, insurable, and standardized.
Midlife care is next. The models are here. Margin models are maturing. The demand signals are increasingly clear.
At FemmeHealth Ventures, we are tracking this shift closely not just to spotlight founders, but to help capital allocators see what’s structurally changing.
If you are investing, operating, or just watching closely, we’d love to be in conversation.
Because what gets funded shapes what gets built.
And what gets built will determine whether this system starts working for the people who’ve long been written out of it.
Let’s not miss it.
P.S. Our latest Signal Not Noise is live: Read the roundup for sharp takes on Granite Bio’s $100M autoimmune play, LifeMD’s quiet menopause deal, and the emergence of outcome-driven diagnostics in IVF. No hype. Just signal.
Sources:
Carrot Fertility. (n.d.). Fertility benefits for modern companies. https://www.get-carrot.com/
ElektRa Health. (n.d.). Modern menopause care for every woman. https://www.elektrahealth.com/
GlobeNewswire. (2025, April 28). LifeMD acquires women’s health provider Optimal Human Health MD to accelerate entry into the women’s health market.
Hello Bonafide. (n.d.). Clinical trials. https://hellobonafide.com/pages/clinical-trials
Mercer. (2024, January). Employers enhance health benefits in 2024, adding coverage for weight-loss medications and IVF.
Midi Health. (2024, January 30). Midi Health expands access to women’s care across all 50 states. MobiHealthNews. https://www.mobihealthnews.com/news/midi-health-expands-womens-care-access-all-50-states
Pharmavite. (2024, September). Bonafide Health launches Thermella—first NK3R antagonist for menopause symptom management.
Progyny. (n.d.). Smarter fertility benefits for the modern workplace. https://www.progyny.com/
Peppy Health (n.d.). These are Europe’s top startups tackling menopause | Sifted
Ways to Connect with FemmeHealth Ventures Alliance
Thanks for reading. If you liked what you read, consider:
signing up for FemmeHealth newsletter, which is published weekly
sending to a friend or co-worker
Thanks for reading FemmeHealth Ventures Alliance! Subscribe for free to receive new posts and support my work.
Disclaimer & Disclosure
This content is for informational and educational purposes only. It does not constitute financial, investment, legal, or medical advice, or an offer to buy or sell any securities. Opinions expressed are those of the author and may not reflect the views of affiliated organisations. Readers should seek professional advice tailored to their individual circumstances before making investment decisions. Investing involves risk, including potential loss of principal. Past performance does not guarantee future results.
“ build a new system” you know that’s my vote. Stop trying to make us equal to men and just give us a whole new paradigm. That’s just for women and our bodies! Especially since I’m in the stage of life that makes me super excited, even though it might be a little behind what I need. Will definitely be watching this closely with you.
I also think I got excited to hear that I only took 10 years for things to shift around fertility. Let’s drive this shift quickly, please 😂
Absolutely in awe about how you lay this out! SO great to have someone put context around how changes we have difficulty seeing any one month or year can lead to a tipping point among investors and employers. This is just masterful! (and, of course, going right to my peeps tomorrow!) thanks so much for the way your mind works--it adds so much to what for many of us is more passion than strategy!